Bausch + Lomb Corporation (BLCO)

NYSE: BLCO · Real-Time Price · USD

21.32

-0.05 (-0.23%)

At close: Nov 11, 2026, 4:00 PM EST

21.35

+0.03 (0.14%)

Pre-market: Nov 12, 2026, 8:17 AM EST

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
U.S. and Puerto Rico Revenue	2.55B	2.41B
Total International Revenue	2.56B	2.38B
Revenue (Total)	5.10B	4.79B

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Vision Care Revenue	3.05B	2.92B	2.74B
Surgical Revenue	967.00M	894.00M	843.00M
Ophthalmic Pharmaceuticals Revenue	1.40B	1.28B	1.21B
Revenue (Total)	-	5.10B	4.79B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceuticals Revenue	1.20B	1.08B	969.00M
Devices Revenue	2.04B	1.92B	1.80B
OTC Revenue	1.91B	1.83B	1.72B
Branded and Other Generics Revenue	246.00M	243.00M	281.00M
Total Product Revenue	5.40B	5.08B	4.77B
Other Product Revenue	21.00M	21.00M	17.00M
Revenue (Total)	-	5.10B	4.79B

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Vision Care Segment Profit	922.00M	849.00M	808.00M
Ophthalmic Pharmaceuticals Segment Profit	423.00M	258.00M	256.00M
Surgical Segment Profit	73.00M	18.00M	44.00M
Corporate Segment Profit	-681.00M	-679.00M	-614.00M
Amortization of Intangible Assets	-227.00M	-258.00M	-288.00M
Net Other Expense	-127.00M	-75.00M	-44.00M
Operating Income (Total)	-	113.00M	162.00M

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Vision Care Revenue Change in Constant Currency	5.00%	10.00%
Surgical Revenue Change in Constant Currency	6.00%	11.00%
Ophthalmic Pharmaceuticals Revenue Change in Constant Currency	4.00%	45.00%
Total Revenue Change in Constant Currency	6.00%	17.00%